Status | Study |
Recruiting |
Study Name: Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Condition: Charcot-Marie-Tooth Disease Date: 2017-04-12 Interventions: Drug: ACE-083 Part 1 - Recombinant fusion protein. Part 2 - Recombinant fusion protein or buffer solutio |
Recruiting |
Study Name: Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Condition: Charcot-Marie-Tooth Disease, Type IA Date: 2016-12-26 Interventions: Drug: PXT3003 Liquid oral solution, 5 mL bid for 9 consecutive months |
Recruiting |
Study Name: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Condition: Chronic Inflammatory Demyelinating Polyneuropathy Peripheral Neuropathy Date: 2016-11-08 Interventions: Drug: MD1003 |
Not yet recruiting |
Study Name: Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers Condition: Charcot-Marie-Tooth Disease Type 1A Date: 2015-10-30 Interventions: Other: Clinical evaluation Other: electrop |
Active, not recruiting |
Study Name: Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Condition: Charcot-Marie-Tooth Disease Type 1A Date: 2015-09-28 Interventions: Drug: PXT3003 dose 1 Liquid or |
Not yet recruiting |
Study Name: Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A Condition: Charcot-Marie-Tooth Type 1A Neuropathy Date: 2012-11-16 |
Completed |
Study Name: Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Condition: Charcot-Marie-Tooth Disease Hereditary Neuropathy With Liability to Pressure Palsies Date: 2011-07-20 Interventions: Drug: PXT3003 Low dose Liquid, |
Active, not recruiting |
Study Name: Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Condition: Charcot-Marie-Tooth Disease Charcot-Marie-Tooth Disease Type 1A Date: 2011-01-24 Interventions: Other: TreSPE |
Completed |
Study Name: High Dose Ascorbic Acid Treatment of CMT1A Condition: Charcot-Marie-Tooth Disease, Type Ia Date: 2007-06-08 Interventions: Drug: Ascorbic acid (Vitamin C) |
Completed |
Study Name: Ascorbic Acid Treatment in CMT1A Trial (AATIC) Condition: Charcot-Marie-Tooth Disease Hereditary Motor and Sensory Neuropathies Date: 2006-01-03 Interventions: Drug: Placebo Placebo 4 capsul |